 |
|
|
| |
Integrated Efficacy Analysis of Bulevirtide 10 mg From Studies MYR204 and MYR301 at Weeks 48 and 96 Across Subgroups
|
| |
| |
EASL 2026 May 26-30 Barcelona
Adrian Streinu-Cercel1,2, Soo Aleman3, Tarik Asselah4, Maurizia Brunetto5,6, Vladimir Chulanov7, George Sebastian Gherlan2,8, Pietro Lampertico9,10, Viacheslav Morozov11, Olga Sagalova12, Tatiana Stepanova13, Sreeni Yalamanchili14, Amos Lichtman14, Dmitry Manuilov14, Mingyang Li14, Heiner Wedemeyer15
|
| |
|
|
|
|
|
